Emil T. Kuriakose
Corporate Officer/Principal en TERNS PHARMACEUTICALS, INC. .
Fortuna: 272 684 $ al 30/04/2024
Cargos activos de Emil T. Kuriakose
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| TERNS PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2023 | - |
Historial de carrera de Emil T. Kuriakose
Antiguos cargos conocidos de Emil T. Kuriakose.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Novartis Oncology, Inc.
 Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Director Técnico/Científico/I+D | 01/07/2013 | 01/01/2016 |
| CALITHERA BIOSCIENCES, INC. | Director Técnico/Científico/I+D | 01/08/2017 | - |
Formación de Emil T. Kuriakose.
| Stony Brook University School of Medicine | Doctorate Degree |
| New York University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 6 |
Operativa
| Chief Tech/Sci/R&D Officer | 2 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CALITHERA BIOSCIENCES, INC. | Health Technology |
| TERNS PHARMACEUTICALS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Novartis Oncology, Inc.
Novartis Oncology, Inc. Pharmaceuticals: MajorHealth Technology Novartis Oncology, Inc. provides healthcare solutions. The firm offers medicines, eye care and generic pharmaceuticals. It also offers patient declaration, patient support and assistance, and additional resources. The company is headquartered in East Hanover, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Emil T. Kuriakose
- Experiencia
